ArticleHuman vaccines & immunotherapeutics2022

Effectiveness of COVID-19 vaccine (Covaxin) against breakthrough SARS-CoV-2 infection in India.

Priyamadhaba Behera et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.